Vir Biotechnology is handing off certain commercial rights for its hepatitis D program to European specialty pharma Norgine in a licensing deal that’s worth up to 550 million euros ($645 million) and ...

Vir Biotechnology plans to give an exclusive license for the commercial rights to a chronic hepatitis delta treatment to an affiliate of Norgine. The biopharmaceutical company said Tuesday the license ...

Many racetracks have succumbed to high real-estate prices in recent years, their sweeping turns or steep banking replaced by subdivisions or warehouses. At least for now, Virginia International ...

Actor-comedian Vir Das is set to make his directorial debut with an upcoming spy-comedy film, Happy Patel: Khatarnak Jasoos, backed by Aamir Khan Productions. The banner made the announcement by ...

– Phase 1 clinical trial designed to assess the safety, pharmacokinetics and preliminary efficacy of VIR-5500 in combination with androgen receptor pathway inhibitors in first-line mCRPC – Clinical ...

Tamarind is a tropical fruit that offers several potential health benefits due to its rich nutrient content and bioactive compounds. Tamarind contains vitamins, minerals, antioxidants, and fiber. It ...

Imli in English: Imli is one of the most important ingredients in Indian cuisine, loved for its tangy and sour taste. Its unique flavour is used in chutneys, curries, snacks, street food, pickles, and ...

Imli isn’t just for chaat. This tangy, dark, sticky delight has been spicing up Indian kitchens for centuries. From chutneys to the golgappewala’s magic water, tamarind knows how to make your taste ...

Hello. Welcome to Vir Biotechnology's Second Quarter 2025 Financial Results and Corporate Update Call. As a reminder, this conference call is being recorded. [Operator Instructions] I will now turn ...

Vir Das is one of the most successful and internationally recognized stand-up comedians from India, but his rise to global fame hasn’t come without hurdles. With multiple comedy specials, films, and ...

Marianne De Backer, PhD, MBA, CEO of Vir Biotechnology, has led the company's pivot to focusing on cancer as well as infectious diseases. [Vir Biotechnology] Between launching clinical studies for its ...